Giovanna Yazmin Arteaga Muller

Dr. Giovanna Yazmin Arteaga Muller

Nephrology, Hospital Universitario Dr José Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
GMGiovanna Yazmin Arteaga Muller
Giovanna Yazmin Arteaga Muller
SFSamantha Flores-Treviño
Samantha Flores-Treviño
PBPaola Bocanegra-Ibarias
Paola Bocanegra-Ibarias
RGRobles Espino Diana Guadalupe
Robles Espino Diana Guadalupe
Elvira Garza-GonzálezElvira Garza-González
Elvira Garza-González
ACAdrián Camacho-Ortiz
Adrián Camacho-Ortiz
Chronic kidney disease (CKD) is a progressive loss of renal function in which gut dysbiosis is involved. Fecal microbiota transplantation (FMT) may be a promising alternative for restoring gut microbiota and treating CKD. This study evaluated the changes in CKD progression in patients treated with FMT. Patients with diabetes and/or hypertension with CKD clinical stages 2, 3, and 4 in this single-center, double-blind, randomized, placebo-controlled clinical trial (NCT04361097) were randomly assigned to receive either FMT or placebo capsules for 6 months. Laboratory and stool metagenomic analyses were performed. A total of 28 patients were included (15 FMT and 13 placebo). Regardless of CKD stages, patients responded similarly to FMT treatment. More patients (53.8%) from the placebo group progressed to CKD than the FMT group (13.3%). The FMT group maintained stable renal function parameters (serum creatinine and urea nitrogen) compared to the placebo group. Adverse events after FMT treatment were mild or moderate gastrointestinal symptoms. The abundance of Firmicutes and Actinobacteria decreased whereas Bacteroidetes, Proteobacteria and Roseburia spp. increased in the FMT group. CKD patients showed less disease progression after FMT administration. The administration of oral FMT in patients with CKD is a safe strategy, does not represent a risk, and has potential benefits.

1 December 2020 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
SSSergio Raúl Alvizures Solares
Sergio Raúl Alvizures Solares
HIHéctor Raúl Ibarra-Sifuentes
Héctor Raúl Ibarra-Sifuentes
MRMaría Guadalupe Ramírez Ramírez
María Guadalupe Ramírez Ramírez
GMGiovanna Yazmin Arteaga Muller
Giovanna Yazmin Arteaga Muller
JVJesús Cruz Valdez
Jesús Cruz Valdez
Introduction: Idiopathic nodular glomerulosclerosis (ING) is a condition that has a vasculopathic glomerular histological pattern. Case presentation: The authors present the case of a 44-year-old Hispanic smoker female with hypertension and peripheral arterial disease who presented nephrotic syndrome for 2 weeks. The patient was diagnosed with ING by percutaneous renal biopsy results, which showed global nodular mesangial matrix expansion, with linear staining accentuation of glomerular and tubular basement membrane for Immunoglobulin G (IgG) and albumin on immunofluorescence. Conclusions: ING is a rare disease with a poor renal prognosis and wide diagnostic approach; we highlight the importance of analyzing every piece of detail together to reach a definitive diagnosis.